Reply to the letter “Long term effects of nocturnal hypoxia and urinary uric acid excretion: How much linked to COPD and OSAS?”  by Varol, Y. & Ucar, Z.Z.
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ar  Editor,
 have  read  the  letter  titled  ‘‘Long  term  effects  of  noc-
nal  hypoxia  and  urinary  uric  acid  excretion:  How  much
ked  to  COPD  and  OSAS?’’  regarding  our  manuscript  ‘Uri-
ry  uric  acid  excretion  as  an  indicator  of  severe  hypoxia
d  mortality  in  patients  with  obstructive  sleep  apnea  and
ronic  obstructive  pulmonary  disease’.  First,  we  would  like
thank  to  Dr  Gomes  and  colleagues  for  their  interest  in
r  study.  We  are  grateful  for  the  insightful  comments  to
r  article  and  are  happy  to  respond  to  their  comments  as
lows.
First  of  all  COPD  and  OSA  have  different  mechanisms
for  hypoxemia  as  mentioned.  Furthermore  intermittent
and  chronic  hypoxemia  has  different  effect  on  diseases
too.  It  would  be  very  useful  to  compare  these  results  on
uric  acid  levels  in  both  diseases,  but  unfortunately  as
we  mentioned  in  our  manuscript  we  did  not  have  enough
participants  to  make  this  sub-group  analysis.
As  the  author  mentioned  there  is  no  universal  deﬁnition
in  the  grading  of  nocturnal  intermittent  hypoxemia.1 It  is
neither  wrong  nor  faultless  to  use  >10%  or  >30%  of  sleep
time.2--3 It  would  be  more  useful  to  use  both  criteria  and
compare  the  results  in  a  large  group  of  patients.
All  the  COPD  patients  were  taking  maximal  pharmaco-
logical  and  non-pharmacological  therapy  according  to
the  GOLD  guidelines.  But  it  is  a  very  nice  comment  toDOI of refers to article: http://dx.doi.org/10.1016/j.rppnen.
6.04.004ment  strategy.
Hypertension  was  the  case  for  approximately  15%  of
our  patients,  which  could  decrease  UA  excretion.  How-
ever,  the  analysis  did  not  reveal  a  signiﬁcant  difference
between  hypertensive  and  normotensive  patients.
We  believe  that  further  clinical  trials  investigating  the
ect  of  nocturnal  progressive  and  intermittent  hypox-
ia  on  COPD  and  OSA  patients  are  needed  to  conﬁrm  our
ults.
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